Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study

AIMS: Selective serotonin re-uptake inhibitors (SSRIs), specifically citalopram and escitalopram, are thought to cause QT(c) prolongation, although studies have shown contradictory results. Nevertheless, a maximum citalopram dosage of 20 mg in high risk patients (e.g. >60 years of age) is recomme...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Clin Pharmacol
Autori principali: Maljuric, Nevena M, Noordam, Raymond, Aarts, Nikkie, Niemeijer, Maartje N, van den Berg, Marten E, Hofman, Albert, Kors, Jan A, Stricker, Bruno H, Visser, Loes E
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2015
Soggetti:
Drug Safety
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4594706/
https://ncbi.nlm.nih.gov/pubmed/25966843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12681
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi